Schering Looks Ahead To Simponi Launch In Canada, Europe After Sluggish Q1

Canadian launch of the once-monthly anti-TNF is targeted for the second half; the market represents the first approval for the biologic.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography